Billionaire Profile
Jiang Rensheng & family
Global Rank
#827

Image: Unsplash Contributor | Unsplash License | via Unsplash

Jiang Rensheng & family

CEO, Vaccines
CHINA
Real-Time Net Worth
$5.215B
Estimated based on Vaccines stock value as of April 21, 2026
-0.7% (24h)
Age
72
Source
Vaccines
Industry
Healthcare
Citizenship
CHINA

Biography

Jiang Rensheng, the chairman of Zhifei Biological Products, a leading Chinese vaccine manufacturer, and his family have built a significant fortune through their contributions to the healthcare industry. With a current net worth of $5.3 billion, Jiang's career began in education and government health roles before he became an entrepreneur. His strategic leadership of Zhifei, and its early success as the first privately-run vaccine enterprise on the ChiNext board, demonstrates his business acumen and commitment to public health. Jiang's wealth reflects his company's success in vaccine development and distribution, particularly with its contributions to addressing global health challenges.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/21/2026

Wealth Over Time

In-Depth Profile

Early Life

Jiang Rensheng was born in China in 1953. Details about his early life remain undisclosed. After graduating high school, he taught in a primary school for seven years and worked in the fields. He later graduated from Guilin Medical University.

Rise to Success

Jiang's career began at the Guanyang County Epidemic Health and Forecasting Center. He moved to Nanning, the provincial capital, and became Deputy Head of the Vaccination Unit and Head of the Biology Department. At the age of 46, Jiang entered the private sector. He became an entrepreneur by taking over a vaccine developer in Chongqing, marking the start of Zhifei Biological Product. His first success was being the sole distributor in China for the meningitis C vaccine. Later, he secured a contract with Merck for the HPV vaccine.

Key Business Strategies

Jiang founded Zhifei Biological Products Co., Ltd. in 2002. In September 2010, it was listed on the Shenzhen Stock Exchange (ChiNext), becoming the first privately-run vaccine enterprise listed on ChiNext. Zhifei is a high-tech biological enterprise integrating R&D, production, marketing, distribution, and import/export. The company's success grew through direct sales of proprietary vaccines and distribution agreements.

Philanthropy

Jiang's company has donated RMB 10 million to Hubei province for pandemic control and regularly contributes to various associations, rural schools, and university libraries.

Career Milestones

N/A

Primary School Teacher

Began his career as a primary school teacher.

N/A

Government Health Official

Became a government health official in the healthcare sector.

2002

Founded Zhifei Biological Product

Founded Zhifei Biological Product, a vaccine manufacturer.

2010

Zhifei went public

Zhifei went public in Shenzhen, becoming the first private vaccine company listed on ChiNext.

2018

Secured sales rights for Merck's HPV vaccine

Zhifei won the Chinese sales rights to the U.S. pharma's HPV drug.

2023

Chongqing Genrix Biopharmaceutical went public

Jiang took his antibody drug maker Chongqing Genrix Biopharmaceutical public on the Shanghai Stock Exchange.

Philanthropy & Social Impact

Public Health

Donations to Hubei Province

$1.4B (10 million RMB)

Donated to Hubei province for pandemic control.

Education and Community Support

Contributions to various Associations, Schools and Libraries

Unknown

Regularly contributes to various associations, rural schools, and university libraries.

Business Philosophy & Leadership

Notable Quotes

"Wealth isn't the true measure of success, social responsibility is."

Leadership Principles

Social Benefits over Corporate Profits

Prioritizing social benefits over corporate profits, as stated in the company's business principle.

Innovation and Quality

Focusing on innovation, quality, and social responsibility.